Literature DB >> 15365274

More about prehypertension.

Marvin Moser.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15365274      PMCID： PMC8109306          DOI： 10.1111/j.1524-6175.2004.03790.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  6 in total

Review 1.  Why less severe degrees of hypertension should be treated.

Authors:  M Moser; R W Gifford
Journal:  J Hypertens       Date:  1985-10       Impact factor: 4.844

2.  Mortality rates after 10.5 years for participants in the Multiple Risk Factor Intervention Trial. Findings related to a priori hypotheses of the trial. The Multiple Risk Factor Intervention Trial Research Group.

Authors: 
Journal:  JAMA       Date:  1990-04-04       Impact factor: 56.272

3.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

4.  Association between prehypertension status and inflammatory markers related to atherosclerotic disease: The ATTICA Study.

Authors:  Christina Chrysohoou; Christos Pitsavos; Demosthenes B Panagiotakos; John Skoumas; Christodoulos Stefanadis
Journal:  Am J Hypertens       Date:  2004-07       Impact factor: 2.689

5.  Random thoughts on guidelines: how are they determined? are they followed?

Authors:  Marvin Moser
Journal:  J Clin Hypertens (Greenwich)       Date:  2004-07       Impact factor: 3.738

6.  Hypertension treatment guidelines.

Authors:  Marvin Moser; Vasilios Papademetriou; Thomas G Pickering; Domenic A Sica
Journal:  J Clin Hypertens (Greenwich)       Date:  2004-08       Impact factor: 3.738
  6 in total
  1 in total

Review 1.  Update on the management of hypertension: recent clinical trials and the JNC 7.

Authors:  Marvin Moser
Journal:  J Clin Hypertens (Greenwich)       Date:  2004-10       Impact factor: 3.738
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.